EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

John S Tanaka, Rebecca R Young, Sarah M Heston, Kirsten Jenkins, Lisa P Spees, Anthony D Sung, Kelly Corbet, Jillian C Thompson, Lauren Bohannon, Paul L Martin, Andre Stokhuyzen, Richard Vinesett und 6 weitere

Biology of Blood and Marrow Transplantation · 2020-11 · 26 (11) · 2053-2060

DOI: 10.1016/j.bbmt.2020.07.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biology of Blood and Marrow Transplantation, 2020-11. Verfasst von John S Tanaka und 17 weiteren Autor:innen. Beteiligte Einrichtung: Duke University School of Medicine, Durham, North Carolina. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, AHRQ HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationAdultAnaerobiosisAnti-Bacterial AgentsChildHumansRetrospective StudiesTransplantation, Homologous

Stichwörter der Autor:innen

CarbapenemsFebrile neutropeniaGut microbiomePiperacillin-tazobactam

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Duke University School of Medicine, Durham, North Carolina.
  • Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, North Carolina.
  • Department of Health Policy and Management, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, North Carolina; Lineberger Comprehensive Cancer Center, University of North…
  • Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
  • Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, North Carolina.
  • Center for Microbiome Research, University of Massachusetts Medical School, Worcester, Massachusetts; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachu…

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • AHRQ HHS
  • NCI NIH HHS
  • NICHD NIH HHS
  • Derfner Foundation
  • Agency for Healthcare Research and Quality
  • National Cancer Institute

Zitieren

APA

Tanaka, J. S., Young, R. R., Heston, S. M., Jenkins, K., Spees, L. P., Sung, A. D., Corbet, K., Thompson, J. C., Bohannon, L., Martin, P. L., Stokhuyzen, A., Vinesett, R., Ward, D. V., Bhattarai, S. K., Bucci, V., Arshad, M., Seed, P. C., & Kelly, M. S. (2020). Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 26(11), 2053-2060. https://doi.org/10.1016/j.bbmt.2020.07.011

Vancouver

Tanaka JS, Young RR, Heston SM, Jenkins K, Spees LP, Sung AD, et al. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2020;26(11):2053-2060. doi:10.1016/j.bbmt.2020.07.011

BibTeX
@article{Tanaka2020,
  author = {Tanaka, John S and Young, Rebecca R and Heston, Sarah M and Jenkins, Kirsten and Spees, Lisa P and Sung, Anthony D and Corbet, Kelly and Thompson, Jillian C and Bohannon, Lauren and Martin, Paul L and Stokhuyzen, Andre and Vinesett, Richard and Ward, Doyle V and Bhattarai, Shakti K and Bucci, Vanni and Arshad, Mehreen and Seed, Patrick C and Kelly, Matthew S},
  title = {Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation},
  journal = {Biology of Blood and Marrow Transplantation},
  year = {2020},
  volume = {26},
  number = {11},
  pages = {2053--2060},
  doi = {10.1016/j.bbmt.2020.07.011}
}
Kostenlos starten →